Alnylam Pharmaceuticals | ALNY - 贷款资金

金融业

USD

USD 5.13B

现金及等价物

USD 1.71B

USD 211.12M

USD 4.22B

USD 1.35B

USD 1.28B

USD 137.59M

USD 145.22M

2.23K

EPS每股收益

USD 1.99

股本和储备

USD 1.08B

USD 825.01M

债务利息支出

USD 69.29M

USD 26.63M

USD 2.48B

USD 38.13B

USD 205.99M

USD 898.54M

USD 137.59M

普通股股本

USD 133.44M

80.04

USD 221.65M

USD 1.17B

销售和管理费用

USD 282.51M

USD 200.15M

贸易债权人

USD 126.63M

应收帐款人

USD 883.96M

	贷款资金	更改		日
Acadia Pharmaceuticals	USD 0		0	2025-03
Agios Pharmaceuticals	USD 1.06M		0	2022-09
Alnylam Pharmaceuticals	USD 2.48B		931K	2026-03
Amgen	USD 51.89B		1.88B	2026-03
Arrowhead Research	USD 1.23B		687.3M	2026-03
BioCryst Pharmaceuticals	USD 395.2M		33.48M	2026-03
BioMarin Pharmaceutical	USD 1.43B		833.11M	2026-03
Incyte	USD 29.41M		785K	2026-03
Ionis Pharmaceuticals	USD 1.91B		9M	2026-03
Moderna	USD 603M		7M	2026-03
Neurocrine Biosciences	USD 169.5M		500K	2023-03
Novartis	USD 29.59B		5.35B	2025-12
PTC Therapeutics	USD 286.94M		1.74B	2026-03
Regeneron Pharmaceuticals	USD 1.99B		719.7M	2026-03
Sangamo BioSciences	USD 0		0	2022-06
Sanofi	EUR 15.72B		150.06M	2025-12
Sarepta Therapeutics	USD 838.16M		9.19M	2026-03
Takeda	JPY 4.37T		99.51B	2026-03
Tectonic Therapeutic	USD 43K		57K	2025-12
Ultragenyx Pharmaceutical	USD 1.13B		19M	2026-03
Vertex Pharmaceuticals	USD 106.7M		4.7M	2025-12
Xencor	USD 82.12M		5.64M	2026-03